Peptides Derived from Fibronectin with Improved Bioactivity and Reduced Susceptibility to Neutrophil Elastase Degradation

• 收藏
• 分享

专利权人:

NeoMatrix Therapeutics Inc.

发明人:

Richard August Clark,Fubao Lin

申请号：

US16341686

公开号：

US20200223903A1

申请日:

2017.10.12

申请国别(地区):

US

年份:

2020

代理人:

摘要：

Polypeptides derived from fibronectin are presented that are neutrophil elastase-resistant and can bind to growth factors and/or enhance growth factor activity. These polypeptides are useful for enhancing wound healing in a patient.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/